
Syngene International Investor Relations Material
Latest events

Q4 24/25
Syngene International
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Syngene International Limited
Access all reports
Syngene International Ltd engages in the provision of contract research and manufacturing services to the pharmaceutical, nutrition, and plant biology industries. It offers a comprehensive range of services from discovery support to manufacture of life-enabling therapies.
The company is involved in three principal activities: providing drug discovery research services; drug development services; and manufacture of active pharmaceutical ingredients & Intermediates, Recombinant proteins, Bioagrochemicals, Biosimilars & Biogenerics and also offering third party research & manufacturing services, including custom synthesis projects. The company was incorporated in 1993 and is headquartered in Bengaluru, India.
Key slides for Syngene International Limited


Q1 24/25
Syngene International Limited


Q1 24/25
Syngene International Limited
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
SYNGENE
Country
🇮🇳 India